NYSE · Medical - Healthcare Information Services

CTEV (CTEV) Stock

$39.35 -1.21% NYSE: CTEV Healthcare

Valuation

MetricValue
Price$39.35
Market Cap$670.83M
P/E Ratio-2.21
P/B Ratio-2.16
P/S Ratio0.64
EPS (TTM)$0.00
52-Week High$74.07
52-Week Low$11.50
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE139.56%
ROA-5.94%
ROCE1.08%
Gross Margin4.66%
Operating Margin4.66%
Net Margin-28.46%
Debt/Equity-15.69
Current Ratio0.86

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.1B$1.1B$962.0M$931.0M$965.0M
Operating Profit$386.0M$-363.0M$162.0M$-1.4B$45.0M
Net Profit$102.0M$-573.0M$-92.0M$-1.6B$-284.0M
EPS$6.40$-35.87$-5.69$-101.92$-17.30
Op Margin34.5%-33.6%16.9%-149.3%4.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$8.2B$7.4B$7.0B$5.2B$4.9B
Total Liabilities$5.9B$5.6B$5.3B$5.1B$5.1B
Cash$185.0M$334.0M$72.0M$17.0M$17.0M
Borrowings$4.9B$4.8B$4.6B$4.5B$4.6B

Latest News

UnitedHealth Group (UNH) Faces Wider DOJ Antitrust Probe As Claritev Review Expands Simply Wall St. · Jul 14, 2026 Sector Update: Healthcare Stocks Fall Late Afternoon MT Newswires · Jul 14, 2026 Update: Market Chatter: DOJ Expands Antitrust Probe Into Claritev MT Newswires · Jul 14, 2026 Sector Update: Healthcare Stocks Fall Tuesday Afternoon MT Newswires · Jul 14, 2026 Market Chatter: DOJ Expands Antitrust Probe Into Claritev MT Newswires · Jul 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$405.0M$372.0M$172.0M$108.0M$117.0M
Investing Cash Flow$-313.0M$-194.0M$-359.0M$-236.0M$-251.0M
Financing Cash Flow$-104.0M$-2.0M$-16.0M$-13.0M$-4.0M
Net Cash Flow$62.0M$152.0M$-259.0M$-52.0M$-1.0M
Free Cash Flow$320.0M$283.0M$63.0M$-11.0M$-12.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.03
EV / EBITDA8.89
FCF Yield-2.80%
Quick Ratio1.00
Interest Coverage0.12
Return 1Y-46.80%
Return 3Y-70.62%
Return 5Y-90.03%

Ownership

Insiders Held7.45%
Institutions Held91.02%
Institutions Float Held98.34%
Institutional HolderSharesReport Date
H&F Corporate Investors VIII, Ltd.3,887,8582026-03-31
Ares Management LLC1,863,1052026-03-31
Arini Captial Management Ltd1,534,6872026-03-31
Public Investment Fund1,281,2502026-03-31
Beach Point Capital Management LP795,3462026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AXGN $49.88 -1.73% 60.40 $2.68B 0.00%
DNTH $106.62 +0.96% -812.38 $5.96B 0.00%
EVH $4.28 -4.89% -0.77 $481.42M 0.00%
GDRX $3.46 -0.86% 28.44 $1.20B 0.00%
IART $16.62 -1.77% -183.51 $1.29B 0.00%

About CTEV

CTEV is led by CEO Travis S. Dalton, publicly traded since 2020.

CTEV stock trades at $39.35 with a market capitalization of $670.83M. The stock is valued at a price-to-earnings (P/E) ratio of -2.21, price-to-book of -2.16, price-to-sales of 0.64. Over the past 52 weeks the stock has ranged between $11.50 and $74.07, and currently trades 46.9% below its 52-week high.

On profitability, CTEV generates a return on equity (ROE) of 139.56% — well above the market average, a sign of a high-quality business, return on capital employed of 1.08%, an operating margin of 4.66%, a net profit margin of -28.46%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.93 +0.28% JNJ Drug Manufacturers - General $271.19 +2.01% ABBV Drug Manufacturers - General $259.99 +1.39% MRK Drug Manufacturers - General $149.94 +1.48% UNH Medical - Healthcare Plans $396.30 +1.77% NVS Drug Manufacturers - General $161.25 +6.04% AZN Drug Manufacturers - General $162.47 +0.21% AMGN Drug Manufacturers - General $438.12 +1.92% TMO Medical - Diagnostics & Research $600.50 -2.69% NVO Biotechnology $45.12 -0.46% ABT Medical - Devices $108.97 -1.26% GILD Drug Manufacturers - General $149.92 +2.45%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides